Statements of Changes in Stockholders' Equity (Deficit) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2023	$ 1,052	$ 102,507,189	$ (110,259,087)	$ (7,750,846)
Balance, shares at Dec. 31, 2023	10,519,933
Changes in Stockholders' Equity (Deficit)
Cashless exercise of stock options	$ 22	(22)
Cashless exercise of stock options, shares	220,339
Stock-based compensation expense		3,836,770		3,836,770
Exercise of common stock warrants, inclusive of warrant reduction	$ 89	17,342,022		17,342,111
Exercise of common stock warrants, inclusive of warrant reduction, shares	891,667
Issuance of common stock, pursuant to Equity Distribution Agreement, net of issuance costs	$ 3	156,766		156,769
Issuance of common stock, pursuant to Equity Distribution Agreement, net of issuance costs, shares	26,788
Issuance of common stock pursuant to ELOC, net of issuance costs	$ 205	16,438,012		16,438,217
Issuance of common stock pursuant to ELOC, net of issuance costs, shares	2,051,428
Issuance of common stock pursuant to registered direct offering, net of issuance costs	$ 43	3,874,957		3,875,000
Issuance of common stock pursuant to registered direct offering, net of issuance costs, shares	431,366
Net loss			(24,590,375)	(24,590,375)
Balance at Dec. 31, 2024	$ 1,414	144,155,694	(134,849,462)	9,307,646
Balance, shares at Dec. 31, 2024	14,141,521
Changes in Stockholders' Equity (Deficit)
Exercise of stock options	$ 1	1,998		$ 1,999
Exercise of stock options, shares	14,284			14,284
Stock-based compensation expense		1,797,676		$ 1,797,676
Issuance of common stock, pursuant to Equity Distribution Agreement, net of issuance costs	$ 212	6,566,622		6,566,834
Issuance of common stock, pursuant to Equity Distribution Agreement, net of issuance costs, shares	2,122,602
Issuance of common stock, warrants, and pre-funded warrants pursuant to registered offerings, net of issuance costs	$ 1,092	28,030,200		28,031,292
Issuance of common stock, warrants, and pre-funded warrants pursuant to registered offerings, net of issuance costs, shares	10,070,732
Exercise of pre-funded common stock warrants, shares	850,000
Net loss			(28,854,197)	(28,854,197)
Balance at Dec. 31, 2025	$ 2,719	$ 180,552,190	$ (163,703,659)	$ 16,851,250
Balance, shares at Dec. 31, 2025	27,199,139